Literature DB >> 29914798

Neuregulin 1 regulates amyloid precursor protein cell surface expression and non-amyloidogenic processing.

Young-Jung Kim1, Ji-Young Yoo1, Ok-Soon Kim1, Han-Byeol Kim1, Junghwa Ryu2, Hye-Sun Kim2, Jun-Ho Lee3, Hong-Il Yoo1, Dae-Yong Song1, Tai-Kyoung Baik4, Ran-Sook Woo5.   

Abstract

The amyloid precursor protein (APP) is a key molecule in Alzheimer's disease. The prevailing view is that APP is initially transported to the plasma membrane as a full-length protein. Its localization at the cell surface can trigger downstream signaling and APP cleavage. Our previous work has shown that Neuregulin 1 (NRG1) has neuroprotective effects in an Alzheimer's disease model. In the present study, we examine whether NRG1 signaling is involved in APP expression and non-amyloidogenic processing in neuronal cells. Here we show that NRG1 increased the cell surface expression of APP without changing the total amount of APP mRNA or protein expression in SH-SY5Y cells and in rat primary cortical neurons. In addition, NRG1 significantly increased the levels of the secreted form of APP, sAPPα, in the conditioned media but did not change the expression of ADAM10 on the cell surface or in the cell lysates. Furthermore, we found that the protein level of NRG1 was reduced in the hippocampus of Alzheimer's disease (AD) patients. Our results demonstrate that NRG1 increased APP expression on the cell surface and sAPPα secretion into the media of neuronal cell cultures. Taken together, these results suggest a role for NRG1 in non-amyloidogenic processing.
Copyright © 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADAM10; Amyloid-precursor protein; Neuregulin 1; Non-amyloidogenic processing; Secreted APPα

Mesh:

Substances:

Year:  2018        PMID: 29914798     DOI: 10.1016/j.jphs.2018.05.004

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  3 in total

1.  ADeditome provides the genomic landscape of A-to-I RNA editing in Alzheimer's disease.

Authors:  Sijia Wu; Mengyuan Yang; Pora Kim; Xiaobo Zhou
Journal:  Brief Bioinform       Date:  2021-09-02       Impact factor: 11.622

2.  Neuregulin-1 inhibits CoCl2-induced upregulation of excitatory amino acid carrier 1 expression and oxidative stress in SH-SY5Y cells and the hippocampus of mice.

Authors:  Han-Byeol Kim; Ji-Young Yoo; Seung-Yeon Yoo; Jun-Ho Lee; Wonseok Chang; Hye-Sun Kim; Tai-Kyoung Baik; Ran-Sook Woo
Journal:  Mol Brain       Date:  2020-11-13       Impact factor: 4.041

3.  Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Hyeon Jeong Seo; Jung Eun Park; Seong-Min Choi; Taekyoung Kim; Soo Hyun Cho; Kyung-Hwa Lee; Woo Keun Song; Juhyun Song; Han-Seong Jeong; Dong Hyun Kim; Byeong C Kim
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.